Experienced Drug Users Assess the Relative Harms and Benefits of Drugs: A Web-Based Survey

Journal of Psychoactive Drugs

Volumn 45, Issue 4, 2013, Pages 322-328

  Carhart Harris, Robin Lester ^a   Nutt, David John ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

drug abuse; drug harms; drug policy; drug users; drugs

Indexed keywords

3, 4 METHYLENEDIOXYMETHAMPHETAMINE; 4' METHYLMETHCATHINONE; AMPHETAMINE; BENZODIAZEPINE; CANNABIS; COCAINE; DIAMORPHINE; KETAMINE; LYSERGIDE; PSILOCYBINE; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ALCOHOLISM; ARTICLE; ATTITUDE TO HEALTH; CANNABIS ADDICTION; DRUG ABUSE; FEMALE; HEALTH SURVEY; HUMAN; MALE; OUTCOME ASSESSMENT; PERSONAL EXPERIENCE; PSYCHOTHERAPY; RISK BENEFIT ANALYSIS;

ADOLESCENT; ADULT; DATA COLLECTION; DRUG USERS; FEMALE; HUMANS; INTERNET; KNOWLEDGE; MALE; MIDDLE AGED; STREET DRUGS;

EID: 84885035464     PISSN: 02791072     EISSN: 21599777     Source Type: Journal    
DOI: 10.1080/02791072.2013.825034     Document Type: Article

References (11)

1. Daniulaityte, R., Falck, R. and Carlson, R.G. 2012. SPiquotSPiI'm not afraid of those ones just 'cause they've been prescribedSPiquotSPi: Perceptions of risk among illicit users of pharmaceutical opioids. International Journal of Drug Policy, 23: 374 - 384.
2. Daniulaityte, R., Falck, R.S., Wang, J. and Carlson, R.G. 2009. Illicit use of pharmaceutical opioids among young polydrug users in Ohio. Addictive Behaviors, 34: 649 - 653.
3. Grob, C.S., Danforth, A.L., Chopra, G.S., Hagerty, M., McKay, C.R., Halberstadt, A.L. and Greer, G.R. 2011. Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer. Archives of General Psychiatry, 68: 71 - 78.
4. MacLean, S. 2008. Volatile bodies: Stories of corporeal pleasure and damage in marginalised young people's drug use. International Journal of Drug Policy, 19: 375 - 383.
5. McLean, C.P. and Anderson, E.R. 2009. Brave men and timid women? A review of the gender differences in fear and anxiety. Clinical Psychology Review, 29: 496 - 505.
6. Mithoefer, M.C., Wagner, M.T., Mithoefer, A.T., Jerome, L. and Doblin, R. 2011. The safety and efficacy of {+/-}3, 4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: The first randomized controlled pilot study. Journal of Psychopharmacology, 25: 439 - 452.
7. Morgan, C.J., Muetzelfeldt, L., Muetzelfeldt, M., Nutt, D.J. and Curran, H.V. 2010. Harms associated with psychoactive substances: Findings of the UK National Drug Survey. Journal of Psychopharmacology, 24: 147 - 153.
8. Nutt, D.J., King, L.A. and Phillips, L.D. 2010. Drug harms in the UK: A multicriteria decision analysis. Lancet, 376: 1558 - 1565.
9. Nutt, D., King, L.A., Saulsbury, W. and Blakemore, C. 2007. Development of a rational scale to assess the harm of drugs of potential misuse. Lancet, 369: 1047 - 1053.
10. Sexton, R.L., Carlson, R.G., Siegal, H.A., Falck, R.S., Leukefeld, C. and Booth, B. 2005. Barriers and pathways to diffusion of methamphetamine use among African Americans in the rural South: Preliminary ethnographic findings. Journal of Ethnicity in Substance Abuse, 4: 77 - 103.
11. van Amsterdam, J. and van den Brink, W. 2010. Ranking of drugs: A more balanced risk-assessment. Lancet, 376: 1524 - 1525.